Hydroxy acids and derivatives
Selleck Chemical LLC 3-Hydroxybutyric acid-25mg
3-Hydroxybutyric acid (3-hydroxybutanoic acid, β-Hydroxybutyric acid, BHB) is a small molecule metabolite that is elevated in type I diabetes.,
Medchemexpress LLC 3-Hydroxybutyric acid sodium | 150-83-4 | 98.0% | 126.09 | 10MM/1ML
3-Hydroxybutyric acid sodium is a metabolite that is elevated in type I diabetes. It can modulate the properties of membrane lipids. It is also capable of interacting with lipids (modeled using a DPPC monolayer) and altering phase behavior at clinical concentrations, and diminishes the interfacial viscosity of DPPC Monolayers.
- Target: Endogenous Metabolite
- Research Areas: Metabolic Disease
- Classification of Application Fields: Ketones, Aldehydes, Acids
- Modulates membrane lipid properties
- Interacts with lipids and alters phase behavior
- Diminishes interfacial viscosity of DPPC Monolayers
Medchemexpress LLC 3-Hydroxybutyric acid-13C4 sodium | 287111-43-7 | 98.0% | 130.06 | 5 MG
3-Hydroxybutyric acid-13C4 sodium is the 13C labeled 3-Hydroxybutyric acid sodium. The unlabeled compound, 3-Hydroxybutyric acid sodium, is a metabolite elevated in type I diabetes and can modulate membrane lipid properties. This product is for research use only and is not sold to patients.
- Can be used as a tracer.
- Can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.
- Appearance: Solid
- Color: White to off-white
- Shipping: Room temperature in continental US; may vary elsewhere.
- Storage: 4°C, sealed storage, away from moisture. In solvent: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture).
- Solubility in water: 25 mg/mL (192.22 mM); needs ultrasonic and warming.
![Medchemexpress LLC 2-Propanol, 1-[4-(2-methoxyethyl)phenoxy]-3-[(1-methylethyl)amino]-, tartrate (2:1) | 56392-17-7 | 100.0% | 342.41 | 500 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000387190-logo.png-250.jpg){kind=logo}
Medchemexpress LLC 2-Propanol, 1-[4-(2-methoxyethyl)phenoxy]-3-[(1-methylethyl)amino]-, tartrate (2:1) | 56392-17-7 | 100.0% | 342.41 | 500 MG
Metoprolol tartrate is an orally active, selective β1-adrenoceptor antagonist, demonstrating anti-inflammation, antitumor, and anti-angiogenic properties. It is intended for research use only and not sold to patients.
- Purity: 99.98%
- Appearance: White to light yellow solid
- Storage: 4°C, sealed storage, away from moisture and light
- In solvent storage: -80°C for 6 months; -20°C for 1 month
![Medchemexpress LLC 2-Propanol, 1-[4-(2-methoxyethyl)phenoxy]-3-[(1-methylethyl)amino]-, (2R,3R)-2,3-dihydroxybutanedioate (2:1) | 56392-17-7 | 99.98% | 342.41 | 25MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000384117-logo.png-250.jpg){kind=logo}
Medchemexpress LLC 2-Propanol, 1-[4-(2-methoxyethyl)phenoxy]-3-[(1-methylethyl)amino]-, (2R,3R)-2,3-dihydroxybutanedioate (2:1) | 56392-17-7 | 99.98% | 342.41 | 25MG
Metoprolol tartrate is characterized as an orally active, selective β1-adrenoceptor antagonist. It has demonstrated various biological activities, including anti-inflammatory, antitumor, and anti-angiogenic properties. Studies have shown its ability to reduce proinflammatory cytokines and atherosclerosis, protect myocardial tissue from viral damage, decrease myocardial virus titers, and inhibit myocardial apoptosis.
- Orally active compound.
- Selective antagonist of a specific adrenoceptor.
- Exhibits anti-inflammatory effects.
- Demonstrates antitumor properties.
- Possesses anti-angiogenic activity.
- Reduces proinflammatory cytokines.
- Decreases atherosclerosis.
- Protects heart muscle from viral damage.
- Lowers myocardial virus titers.
- Inhibits programmed cell death in heart tissue.
Medchemexpress LLC Ketanserin tartrate | 83846-83-7 | MFCD00084651 | 99.9% | 545.51 g/mol | C26H28FN3O9 | 1 ML
Ketanserin tartrate is the tartrate salt of ketanserin, a selective 5-HT2 receptor antagonist that also inhibits hERG current in a concentration-dependent manner. Supplied for research use, it is available as a 10 mM solution in DMSO (1 mL) and as solid quantities, and is accompanied by datasheet, certificate of analysis, and SDS.
Medchemexpress LLC Pyrantel (tartrate) | 33401-94-4 | 98.7% | 356.39 | 500 MG
Pyrantel tartrate is an orally active anthelmintic and an agonist of the nicotinic acetylcholine receptor (nAChR). It induces spasmodic muscle paralysis in parasites, making it useful for studying parasitic infections like ascariasis, hookworm infections, intestinal worms (pinworm infections), and trichinosis.
- Orally active anthelmintic
- Agonist of the nicotinic acetylcholine receptor (nAChR)
- Induces spasmodic muscle paralysis in parasites
- Useful for studying various parasitic infections
Medchemexpress LLC Morantel tartrate | 26155-31-7 | MFCD00079449 | 99.01% | 25 MG
Morantel tartrate is an anthelmintic agent used to control subclinical gastrointestinal parasitism among cattle on pasture. It can be found in ruminal, abomasal, ileal fluids, and feces for over 98 days after administration.
- Controls subclinical gastrointestinal parasitism in cattle.
- Effective against mature forms of various nematodes in cattle.
- Used in other ruminant species.
Medchemexpress LLC Varenicline tartrate | 375815-87-5 | MFCD08460603 | 99.9% | 361.35 | C17H19N3O6 | 50 MG
Varenicline tartrate is the tartrate salt of varenicline, a nicotinic acetylcholine receptor partial agonist. Supplied as a high-purity research chemical for in vitro and analytical applications, it is intended for laboratory use only and not for human or clinical use.
- High purity (≈99.9%).
- CAS number 375815-87-5.
- Molecular weight 361.35 g/mol.
- Appearance: off-white to yellow solid.
- Available in multiple pack sizes, including small milligram quantities and larger bulk options.
- Recommended storage: sealed, away from moisture; in solvent: -80°C (6 months) or -20°C (1 month).
- Biological activity: partial agonist of α4β2 nicotinic acetylcholine receptors (IC50 ≈ 250 nM).
Apexbio Technology LLC Tylosin tartrate 74610-55-2 10mM (in 1mL DMSO)
Tylosin tartrate (CAS 74610-55-2) is a small-molecule inhibitor targeting the bacterial 50S ribosomal subunit It is designed to inhibit bacterial protein synthesis thereby disrupting peptide elongation during translation Tylosin tartrate exerts its biological activity primarily through reversible binding to the 50S ribosomal subunit In microbiological assays tylosin tartrate demonstrates antibacterial activity with IC50 values typically ranging from 0 01 to 0 1 g/mL against mycoplasma strains depending on strain sensitivity Based on these pharmacological properties tylosin tartrate holds research potential in the investigation of antimicrobial mechanisms resistance profiles and bacterial physiology associated with poultry and livestock infections
Medchemexpress LLC Ifenprodil tartrate | 23210-58-4 | 99.9% | 1 ML
Ifenprodil tartrate is a cerebral vasodilator and a noncompetitive NMDA receptor antagonist, with high affinity for NR1A/NR2B receptors. It also acts as an α1 adrenergic receptor antagonist and inhibits GIRK (Kir3) activity. This compound shows inhibitory effects against A/H1N1 strains and offers neuroprotective, anticonvulsant, and antinociceptive properties, making it valuable for research into cerebrovascular diseases and peripheral arterial obliterative disease. This product is supplied as a 10 mM solution in 1 mL.
- Cerebral vasodilator
- Noncompetitive NMDA receptor antagonist
- High affinity for NR1A/NR2B receptors
- Acts as an α1 adrenergic receptor antagonist
- Inhibits GIRK (Kir3)
- Inhibits A/H1N1 strains
- Neuroprotective, anticonvulsant, and antinociceptive
- Used in cerebrovascular and peripheral arterial disease research
Medchemexpress LLC L-glyceric acid sodium | 146298-95-5 | MFCD28363841 | 99.0% | 128.06 g/mol | C3H5NaO4 | 5 MG
L-glyceric acid sodium is the sodium salt of L-glyceric acid, a urinary metabolite that accumulates in L-glyceric aciduria. Supplied as a high-purity analytical reference standard, it is intended for metabolic research and diagnostic applications requiring accurate reference material. The compound has formula C3H5NaO4, molecular weight 128.06 g/mol, and reported purity 99.0%.
- Purity of 99.0%.
- Molecular weight 128.06 g/mol.
- Chemical formula C3H5NaO4.
- Available in small milligram pack sizes for analytical use.
- Intended as an analytical reference for metabolic and diagnostic studies involving L-glyceric aciduria.
Medchemexpress LLC 3-Hydroxybutyric acid-d4 sodium | 1219804-68-8 | 99.7% | 130.11 | 1 MG
3-Hydroxybutyric acid-d4 (sodium) is the deuterium-labeled form of 3-Hydroxybutyric acid. 3-Hydroxybutyric acid (β-Hydroxybutyric acid) is a metabolite known to be elevated in type I diabetes. It can also modulate the properties of membrane lipids.
- Used as a tracer.
- Used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.
Medchemexpress LLC Ifenprodil (tartrate) | 23210-58-4 | 99.9% | 100 MG
Ifenprodil tartrate (NP-120) is a cerebral vasodilator and a noncompetitive NMDA receptor antagonist. It shows high affinity for NR1A/NR2B receptors and acts as an α1 adrenergic receptor antagonist, inhibiting GIRK (Kir3) to reduce inward currents. It exhibits reliable inhibitory effects against A/H1N1 strains and possesses neuroprotective, anticonvulsant, and antinociceptive properties.
- Cerebral vasodilator
- Noncompetitive NMDA receptor antagonist
- High affinity for NR1A/NR2B receptors
- Acts as an α1 adrenergic receptor antagonist
- Inhibits GIRK (Kir3) activity
- Exhibits inhibitory effects against A/H1N1 strains
- Possesses neuroprotective, anticonvulsant, and antinociceptive properties
- Useful for studying cerebrovascular diseases and peripheral arterial obliterative disease
Apexbio Technology LLC Tolterodine tartrate 124937-52-6 100mg
Tolterodine tartrate (CAS 124937-52-6) is the tartrate salt form of tolterodine a small molecule that acts as a competitive antagonist at muscarinic acetylcholine receptors By selectively inhibiting these receptors particularly subtypes involved in urinary bladder contraction tolterodine tartrate reduces detrusor muscle activity This mechanism underlies its utility in studies related to bladder function muscarinic receptor pharmacology and disorders characterized by overactive bladder The compound is commonly employed in preclinical and clinical research investigating the modulation of cholinergic signaling in urological and neurological contexts